Answers are grounded in this paper and cite their sources.
A woman in her 70s was admitted three times over 22 months with recurrent pericardial effusions. A multiplex antinuclear antibody (ANA) assay by chemiluminescent enzyme immunoassay, reported only as a combined index, was repeatedly negative. Reassessment with careful history revealed long-standing Raynaud's phenomenon and episodic abdominal bloating, prompting further evaluation for systemic sclerosis (SSc). Indirect immunofluorescence (IIF) on HEp-2 (human epithelial type 2) cells showed ANA positivity (fine speckled 1:640 and nucleolar 1:320) and ELISA detected anti-RNA polymerase III antibodies, confirming SSc. Because of pre-existing renal impairment and anti-RNA polymerase III positivity, glucocorticoids were avoided; colchicine 0.5 mg/day was started to prevent recurrence. No further pericardial effusion occurred during follow-up. This case illustrates that relying solely on a combined-index multiplex ANA screen can delay diagnosis and that HEp-2 IIF and disease-specific antibody testing are essential when clinical suspicion persists.
No takes yet. Share an insight, caveat, or question.
Omae et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: